Figure S3D from Gene Expression Profiling in BRAF-Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib

Authors :: Antoni Ribas
Yibing Yan
Lukas Amler
Ilsung Chang
Huibin Yue
Luciana Molinero
Priti S. Hegde
Isabelle Rooney
Ivor Caro
Stephen D. Hurst
Mark Kockx
Luc Andries
Jeffrey Sosman
Paolo A. Ascierto
James Larkin
Brigitte Dréno
Grant A. McArthur
Matthew J. Wongchenko
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure S3. Association of the cell cycle/immune signature with B, lactate dehydrogenase levels.

Full Text Access

Tools